Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
Clinical trial NCT05346354 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05346354
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2026-06-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.